Abstract

To avoid detection and targeting by the immune system, the plague-causing bacterium Yersinia pestis uses a type III secretion system to deliver a set of inhibitory proteins into the cytoplasm of immune cells. One of these proteins is an exceptionally active tyrosine phosphatase termed YopH, which paralyzes lymphocytes and macrophages by dephosphorylating critical tyrosine kinases and signal transduction molecules. Because Y. pestis strains lacking YopH are avirulent, we set out to develop small molecule inhibitors for YopH. We used a novel and cost-effective approach, in which leads from a chemical library screening were analyzed and computationally docked into the crystal structure of YopH. This resulted in the identification of a series of novel YopH inhibitors with nanomolar Ki values, as well as the structural basis for inhibition. Our inhibitors lack the polar phosphate-mimicking moiety of rationally designed tyrosine phosphatase inhibitors, and they readily entered live cells and rescued them from YopH-induced tyrosine dephosphorylation, signaling paralysis, and cell death. These inhibitors may become useful for treating the lethal infection by Y. pestis.

Highlights

  • To survive in humans, pathogenic bacteria have evolved numerous mechanisms to evade the immune response in the host [1, 2]

  • To avoid detection and targeting by the immune system, the plague-causing bacterium Yersinia pestis uses a type III secretion system to deliver a set of inhibitory proteins into the cytoplasm of immune cells

  • One of the most successful strategies was adopted by Yersinia pestis, namely a type III secretion system that injects a set of paralyzing proteins directly into the cytoplasm of macrophages and lymphocytes that the bacterium encounters in the lymph nodes of infected individuals [3, 4]

Read more

Summary

Introduction

Pathogenic bacteria have evolved numerous mechanisms to evade the immune response in the host [1, 2]. The natural route of Y. pestis infection is by transmission from infected rats or other animals by blood-sucking fleas, which are weakened by the bacteria in their gut and expel bacterial mass into the epidermis of their victim when trying to feed [5, 6] From these flea bites, the bacteria travel to local lymph nodes [7,8,9], where they multiply and cause a massive lymphadenitis within 2– 6 days [5]. Despite efforts to eradicate the disease, natural reservoirs of Y. pestis still exist in wild rats and other rodent populations in parts of Africa, southeast Asia, and southwestern United States [13], and sporadic human cases of plague still occur every year. A key Yop protein is YopH, a 468-amino acid, exceptionally active protein-tyrosine phosphatase (PTP)1 [29, 30] with a Cterminal catalytic domain and a multifunctional N-terminal domain, which binds tyrosine-phosphorylated target proteins

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call